KRISTINA KLAVERKAMP: Open Payments
NPI 1033734272 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,419 in 186 payments from 14 companies in 2025. Trend: 2023 $2,096 · 2024 $3,418 · 2025 $3,419
Food & beverage: $3,419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $897 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $404 |
| Janssen Biotech, Inc. | 20 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $351 |
| PFIZER INC. | 26 | $346 |
| QOL Medical, LLC | 10 | $229 |
| Madrigal Pharmaceuticals | 9 | $175 |
| Gilead Sciences, Inc. | 8 | $160 |
| GENZYME CORPORATION | 4 | $138 |
| Intercept Pharmaceuticals, Inc. | 7 | $127 |
Products named: RINVOQ, XIFAXAN, TREMFYA, ENTYVIO, VELSIPITY, Sucraid, REZDIFFRA, MAVYRET.
Industry payments across IL — which companies pay providers there.
